EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mapping the immune landscape of PCa: From tumor microenvironment to therapeutics

Shanhe Huang, Yuan Ou, Wei Zhuang, Jinxing Huang, Baojun Wang, Zean Li, Hai Huang

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026

DOI: 10.1016/j.bbcan.2026.189586 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Shanhe Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China; Guangdong Provincial Key Laboratory of Maligna…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Prostatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 363 Literaturangaben. Gefördert von: Beijing Xisike Clinical Oncology Research Foundation, Guangzhou Municipal Science and Technology Program key projects, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) remains a leading cause of cancer-related mortality in men, yet its response to immunotherapy is notably limited compared to other solid tumors. This resistance stems primarily from a highly immunosuppressive tumor microenvironment (TME), characterized by "cold" tumor features such as low mutational burden, scarce cytotoxic T cell infiltration and extensive regulatory cell populations. Building upon the "tumor ecosystem" concept, we integrate emerging insights from single-cell and spatial transcriptomics to decode the spatiotemporal heterogeneity of the PCa ecosystem. We specifically highlight the underappreciated "neural-immune-microbiome" axis-a triangular regulatory network wherein sympathetic nerves suppress T cell motility, intratumoral microbiota drive chronic inflammation, and metabolic reprogramming creates lipid-mediated immune paralysis. We further dissect how cell-type specific remodeling mechanisms, particularly TREM2+ macrophage-mediated metabolic symbiosis, drive the transition from hormone-sensitive to castration-resistant disease. Furthermore, we critically assess how standard of care (ADT, chemotherapy, radiotherapy) and emerging agents (PARPi, HDACi) reprogram the immune landscape with time-dependent, often paradoxical effects. Finally, we propose a roadmap for precision oncology, emphasizing that future success lies in "ecological editing"-biomarker-driven patient stratification and rational combination strategies to overcome the physical and biological barriers of the TME.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentProstatic NeoplasmsHumansMaleAnimalsImmunotherapyMetabolic Reprogramming

Stichwörter der Autor:innen

ImmunotherapyMetabolic reprogrammingNeuro-immune crosstalkProstate cancerTumor microenvironment

Autor:innen und Institutionen

  • Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint La…
  • Department of Urology, The Second Affiliated Hospital of Fujian Medical University, Zhongshan North Road, Licheng District, Quanzhou, Fujian 362000, China.
  • Department of Urology, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
  • Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Bejing 100853, China. Electronic address: baojun40009@126.com.

Förderung

  • Beijing Xisike Clinical Oncology Research Foundation
  • Guangzhou Municipal Science and Technology Program key projects
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China Stem Cell and Translational Research
  • Sixth Affiliated Hospital of Guangzhou Medical University
  • Science and Technology Planning Project of Guangdong Province
  • National Key Research and Development Program of China
  • Guangdong Provincial Applied Science and Technology Research and Development Program

Zitieren

APA

Huang, S., Ou, Y., Zhuang, W., Huang, J., Wang, B., Li, Z., & Huang, H. (2026). Mapping the immune landscape of PCa: From tumor microenvironment to therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189586

Vancouver

Huang S, Ou Y, Zhuang W, Huang J, Wang B, Li Z, et al. Mapping the immune landscape of PCa: From tumor microenvironment to therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2026.189586

BibTeX
@article{Huang2026,
  author = {Huang, Shanhe and Ou, Yuan and Zhuang, Wei and Huang, Jinxing and Wang, Baojun and Li, Zean and Huang, Hai},
  title = {Mapping the immune landscape of PCa: From tumor microenvironment to therapeutics},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  doi = {10.1016/j.bbcan.2026.189586}
}
Kostenlos starten →